Founded in 2000 by an interdisciplinary team of scientists and engineers, INT has addressed not only the technological barriers of streamlining such complex and diverse processes into a portable platform, but has approached it with the input and support of its target customers, governmental agencies, and global foundations.
D. MICHAEL CONNOLLY, PHD
Michael is the Chairman of the Board. He is also President and Chief Executive Officer of the Company. He has a PhD in molecular biology from Northwestern University and completed a post-doctoral fellowship in the Department of Microbiology at the University of Illinois Medical Center. After completing his JD at Cornell University, he practiced as a patent attorney at Nixon Peabody, LLP in Rochester. While at Nixon Peabody, he played a significant role in developing the licensing strategy for a major genetic sequencing enterprise, as well as patenting and licensing technologies for several other companies and universities.
RICHARD S. MURANTE, PHD
SENIOR RESEARCH SCIENTIST
Rick is a Senior Research Scientist with INT, where he plays a pivotal role in the development of the technology. He specializes in biochemistry and molecular biology. He received his PhD in Biochemistry from the University of Rochester. He later went on to be a Research Assistant Professor at the University of Rochester before joining INT in 2000. Rick has multiple publications in the field of molecular biology. He has experience in the genetic computing field and has served as the Principal Investigator on a number of significant federal awards.
JOHN M. NOONAN
John is a Research Chemist at the Company. Prior to joining the Company, he worked as a Senior Research Associate at Eastman Kodak Research Laboratories for over 35 years. He also worked for Corning Glass Works Research Labs as a Research Chemist. He received his M.S. in Organic Chemistry from the University of Delaware and his B.S. in Chemistry from St. Bonaventure University.
Ron joined the company in 2016 as the Chief Financial Officer. Prior to INT, Ron was the Vice President of Biosensors International Group, a $300 million international medical device company, where he also served as General Manager of the U.S. R&D center overseeing the development of novel devices for the treatment of peripheral artery disease. Previously, Ron co-founded Verdant Medical, a start-up focused on treatments for peripheral artery disease (acquired by Biosensors). Ron also served as General Counsel and Corporate Secretary of XTENT, Inc., a NASDAQ-listed medical device company. Ron began his career as a practicing corporate and securities attorney with Silicon Valley Law Group where he focused on financings and M&A transactions for technology startups. Ron holds a Juris Doctor degree and a Masters of Business Administration degree from the University of Maine.
Nate, Design and Process Engineer, joined INT in 2001 to lead the development of chip design and processes. His materials research has led to increased system sensitivity through Palladium’s proprietary microfluidic card design. He received his M.S. and B.S. in Microelectronic Engineering from Rochester Institute of Technology, and his work has been published by SPIE, IEEE, and others.
JANE W. BRYAN
Jane joined the company as Controller in October 2007. Her financial background is varied. She held several positions at the Rochester Institute of Technology in the areas of Sponsored Programs Accounting for grants and contracts, Business Process, Financial Analysis and Internal Audit. While at RIT she also worked on the design and installation of Oracle applications and was the in-house functional manager for two of the applications. At CNA Financial, she was Manager of Financial Policy. Jane also has several years of experience as a CPA with Deloitte & Touche. She is a cum laude graduate of Boston University.
Bob joined the Company as Chief Operating Officer in June 2009. He also serves as Of Counsel to the law firm of Barclay Damon, LLP. Bob has extensive experience in multiple disciplines including law, finance and management, having previously served as the Chief Operating Officer of the Genesee Corporation (a diversified public company), where he had chief executive responsibility for a number of business units, and as Chief Financial Officer of The Case Hoyt Corporation. Bob commenced his legal career at the law firm of Harter, Secrest & Emery and served in several roles including service as the firm’s Managing Partner. He has broad experience with start-up entities and the implementation of capital formation strategies. He currently serves on several boards including Chair of Financial Institutions, Inc. (NASDAQ: FISI) and the University of Rochester Medical Center (Chair, 2011-2012). He is a graduate of Fordham College and earned law degrees from Vanderbilt University (LL.B) and New York University School of Law (LL.M. in Corporate Law).
MARK J. SMITH
DIRECTOR OF MANUFACTURING OPERATIONS
Mark joined the company in 2012 as the Director of Manufacturing Operations. Prior to joining INT, he was the Director of Worldwide Supply Chain and Business Operations for the Consumer Inkjet Division of the Eastman Kodak Company. Mark held a variety of leadership positions with Kodak over the course of a 35-year career, including executive roles in manufacturing, engineering, and development organizations. He received a B.S. in Chemical Engineering from Michigan State University and a certificate in Manufacturing Management from the Darden School at the University of Virginia.
Stay in the know on INT technology!
INT is committed to providing fast, accurate test results that improve biological identification in the field and in operating facilities such as food processing plants. Founded in 2000 by an interdisciplinary team of scientists and engineers, INT has developed a robust platform, Palladium™, for diagnostics and sample processing, replacing traditionally time-sensitive and complex lab processes.